These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 35102401)

  • 1. Immunosuppressant Drugs and Their Effects on Children Undergoing Solid Organ Transplant.
    Spinner JA; Denfield SW
    Pediatr Rev; 2022 Feb; 43(2):71-86. PubMed ID: 35102401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Staphylococcus aureus infections among children receiving a solid organ transplant: clinical features, epidemiology, and antimicrobial susceptibility.
    McNeil JC; Munoz FM; Hultén KG; Mason EO; Kaplan SL
    Transpl Infect Dis; 2015 Feb; 17(1):39-47. PubMed ID: 25573269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppression, Race, and Donor-Related Risk Factors Affect De novo Cancer Incidence Across Solid Organ Transplant Recipients.
    Bhat M; Mara K; Dierkhising R; Watt KDS
    Mayo Clin Proc; 2018 Sep; 93(9):1236-1246. PubMed ID: 30064826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of dyslipidemia in adult solid organ transplant recipients.
    Warden BA; Duell PB
    J Clin Lipidol; 2019; 13(2):231-245. PubMed ID: 30928441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Comprehensive Review of Immunization Practices in Solid Organ Transplant and Hematopoietic Stem Cell Transplant Recipients.
    Chong PP; Avery RK
    Clin Ther; 2017 Aug; 39(8):1581-1598. PubMed ID: 28751095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascularised composite allotransplantation in solid organ transplant recipients: A systematic review.
    Honeyman C; Stark HL; Fries CA; Gorantla VS; Davis MR; Giele H
    J Plast Reconstr Aesthet Surg; 2021 Feb; 74(2):316-326. PubMed ID: 33036926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment and outcomes of immune cytopenias following solid organ transplant in children.
    Schoettler M; Elisofon SA; Kim HB; Blume ED; Rodig N; Boyer D; Neufeld EJ; Grace RF
    Pediatr Blood Cancer; 2015 Feb; 62(2):214-218. PubMed ID: 25308853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 20-year experience with nocardiosis in solid organ transplant (SOT) recipients in the Southwestern United States: A single-center study.
    Majeed A; Beatty N; Iftikhar A; Mushtaq A; Fisher J; Gaynor P; Kim JC; Marquez JL; Mora FE; Georgescu A; Zangeneh T
    Transpl Infect Dis; 2018 Aug; 20(4):e12904. PubMed ID: 29668074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pneumocystis pneumonia in solid organ transplant recipients: not yet an infection of the past.
    Wang EH; Partovi N; Levy RD; Shapiro RJ; Yoshida EM; Greanya ED
    Transpl Infect Dis; 2012 Oct; 14(5):519-25. PubMed ID: 22571389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-Transplantation Diabetes Mellitus in Pediatric Patients.
    Grundman JB; Wolfsdorf JI; Marks BE
    Horm Res Paediatr; 2020; 93(9-10):510-518. PubMed ID: 33789298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention and treatment of tuberculosis in solid organ transplant recipients.
    Abad CL; Razonable RR
    Expert Rev Anti Infect Ther; 2020 Jan; 18(1):63-73. PubMed ID: 31826668
    [No Abstract]   [Full Text] [Related]  

  • 12. Infections in transplant patients.
    Pagalilauan GL; Limaye AP
    Med Clin North Am; 2013 Jul; 97(4):581-600, x. PubMed ID: 23809715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clostridioides difficile infection and recurrence among 2622 solid organ transplant recipients.
    Schluger A; Rosenblatt R; Knotts R; Verna EC; Pereira MR
    Transpl Infect Dis; 2019 Dec; 21(6):e13184. PubMed ID: 31571380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tacrolimus: a further update of its pharmacology and therapeutic use in the management of organ transplantation.
    Plosker GL; Foster RH
    Drugs; 2000 Feb; 59(2):323-89. PubMed ID: 10730553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune function as predictor of infectious complications and clinical outcome in patients undergoing solid organ transplantation (the ImmuneMo:SOT study): a prospective non-interventional observational trial.
    Drabe CH; Sørensen SS; Rasmussen A; Perch M; Gustafsson F; Rezahosseini O; Lundgren JD; Ostrowski SR; Nielsen SD
    BMC Infect Dis; 2019 Jul; 19(1):573. PubMed ID: 31269923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppression following organ transplantation. Part 2: complications and their management.
    Cajanding R
    Br J Nurs; 2018 Oct; 27(18):1059-1065. PubMed ID: 30281349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term respiratory outcomes following solid organ transplantation in children: A retrospective cohort study.
    Wright MFA; Blydt-Hansen T; Chilvers MA
    Pediatr Pulmonol; 2022 Sep; 57(9):2244-2251. PubMed ID: 35546265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features and outcomes of tuberculosis in solid organ transplant recipients.
    Bodro M; Sabé N; Santín M; Cruzado JM; Lladó L; González-Costello J; Carratalà J
    Transplant Proc; 2012 Nov; 44(9):2686-9. PubMed ID: 23146494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orofacial diseases in solid organ and hematopoietic stem cell transplant recipients.
    Petti S; Polimeni A; Berloco PB; Scully C
    Oral Dis; 2013 Jan; 19(1):18-36. PubMed ID: 22458357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosuppression in the pediatric transplant recipient.
    Blondet NM; Healey PJ; Hsu E
    Semin Pediatr Surg; 2017 Aug; 26(4):193-198. PubMed ID: 28964473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.